Health Care Unicycive is all-in on kidney care, focusing on underserved areas: CEO 3 days ago Unicycive Therapeutics, Inc. (NASDAQ: UNCY) is a biotech firm engaged in the development of novel treatment options for patients with… CVS Health raises guidance for FY25 revenue and adjusted earnings 5 days ago Healthcare services company CVS Health (NYSE: CVS) has updated its 2025 full-year financial guidance and issued forecasts for fiscal 2026.… IPO News: What to look for when Lumexa Imaging goes public 5 days ago IPO activity rebounded in the second half of the year, with the technology and healthcare sectors maintaining their dominance in… Earnings Summary: CooperCompanies reports higher Q4 revenue, adj. profit 6 days ago CooperCompanies (NYSE: COO) has reported an increase in revenues and adjusted earnings for the fourth quarter of fiscal 2025. The… MDT Earnings: Medtronic Q2 FY26 revenue and adj. profit beat estimates 4 weeks ago Medical device maker Medtronic plc (NYSE: MDT) on Tuesday reported higher revenues and adjusted earnings for the second quarter of… Advantage of CERo’s CER receptor lies in native human protein-based antigen binding: CEO 1 month ago CERo Therapeutics Holdings, Inc. is a biotechnology company pioneering engineered T cell immunotherapies to combat cancer, with a focus on… Viatris (VTRS) posts Q3 2025 results and updates 2025 guidance 1 month ago Pharmaceuticals company Viatris Inc. (NASDAQ: VTRS) on Thursday reported financial results for the third quarter of fiscal 2025, and updated… Earnings Summary: Humana Q3 2025 profit drops despite higher revenues 1 month ago Humana Inc. (NYSE: HUM), a leading health and well-being company, on Wednesday reported a decline in adjusted earnings for the… Key takeaways from Pfizer’s (PFE) Q3 2025 earnings report 1 month ago Shares of Pfizer Inc. (NYSE: PFE) stayed green during midday trade on Tuesday following the company’s announcement of its third… PFE Earnings: All you need to know about Pfizer’s Q3 2025 earnings results 1 month ago Pfizer Inc. (NYSE: PFE) reported its third quarter 2025 earnings results today. Revenues were $16.7 billion, down 6% on a… Earnings Summary: Highlights of IDEXX’s Q3 2025 report 1 month ago Medical device company IDEXX Laboratories, Inc. (NASDAQ: IDXX) on Monday reported higher revenues and earnings for the third quarter of… ABBV Earnings: A snapshot of AbbVie’s Q3 2025 report 1 month ago Pharmaceuticals company AbbVie, Inc. (NYSE: ABBV) on Friday reported a decline in earnings for the third quarter of fiscal 2025,… BIIB Earnings: A snapshot of Biogen’s Q3 2025 results 1 month ago Biotechnology firm Biogen Inc. (NASDAQ: BIIB) reported an increase in adjusted profit for the third quarter of 2025 when its… Earnings Summary: Cardinal Health Q1 2026 revenue jumps 22%; raises guidance 2 months ago Pharmaceuticals distributor Cardinal Health (NYSE: CAH) reported a sharp increase in revenue and adjusted earnings for the first quarter of… Bristol Myers Squibb (BMY) Earnings: 3Q25 Key Numbers 2 months ago Bristol Myers Squibb (NYSE: BMY) reported its third quarter 2025 earnings results today. Revenues increased 3% year-over-year to $12.2 billion.… Eli Lilly (LLY) Earnings: 3Q25 Key Numbers 2 months ago Eli Lilly and Company (NYSE: LLY) reported its third quarter 2025 earnings results today. Worldwide revenue was $17.60 billion, up… Key highlights from Merck’s (MRK) Q3 2025 earnings results 2 months ago Merck & Co., Inc. (NYSE: MRK) reported its third quarter 2025 earnings results today. Total worldwide sales of $17.3 billion… UnitedHealth Group’s Q3 2025 earnings fall despite double-digit revenue growth 2 months ago Healthcare behemoth UnitedHealth Group (NYSE: UNH) announced results for the third quarter of fiscal 2025, reporting an increase in revenues… Earnings Summary: HCA Healthcare Q3 adj. profit jumps on strong revenue growth 2 months ago Health services behemoth HCA Healthcare, Inc. (NYSE: HCA) has reported a sharp increase in adjusted earnings for the third quarter… Earnings Summary: A snapshot of Revvity’s (RVTY) Q3 2025 report 2 months ago Revvity, Inc. (NYSE: RVTY), a provider of health science solutions and technologies, reported a decline in adjusted earnings for the… Earnings Summary: Highlights of Boston Scientific’s Q3 2025 results 2 months ago Medical device maker Boston Scientific Corporation (NYSE: BSX) on Wednesday reported financial results for the third quarter of 2025. The company… Next»